Are you Dr. Talbot?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl MS 515
Memphis, TN 38105Phone+1 901-595-4060
Summary
- Dr. Lindsay Talbot, MD is a general surgeon in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee, Illinois, and Ohio.
Education & Training
- Duke University School of MedicineClass of 2008
Certifications & Licensure
- TN State Medical License 2018 - 2026
- IL State Medical License 2016 - 2020
- OH State Medical License 2015 - 2017
- NC State Medical License 2008 - 2015
- American Board of Surgery Surgery
- American Board of Surgery Pediatric Surgery
- American Board of Surgery Surgical Critical Care
Publications & Presentations
PubMed
- Use of Palliative Site-Directed Ablation in Pediatric Oncology: A Retrospective Study From the Pediatric Surgical Oncology Research Collaborative.Lindsay J Talbot, Ann Schechter, Suraj Sarvode Mothi, Mecklin Ragan, Jennifer H Aldrink
Pediatric Blood & Cancer. 2025-02-01 - Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models.Lindsay J Talbot, Ashley Chabot, Aaron B Ross, Alexandra Beckett, Phuong Nguyen
Clinical Cancer Research. 2024-10-01 - High-grade osteosarcoma arising from a clinically aggressive infantile fibrosarcoma.Larissa V Furtado, Teresa Santiago, Zachary R Abramson, Marija Kacar, Zonggao Shi
Journal of Clinical Pathology. 2024-09-19
Press Mentions
- Improved Chemokine Homing Enhances CAR T--Cell Therapy for OsteosarcomaAugust 8th, 2024
- Improved Chemokine Homing Enhances CAR T-cell Therapy in Preclinicals for OsteosarcomaAugust 8th, 2024
- Improved CAR T Cell Homing Increases Efficacy of Osteosarcoma TreatmentAugust 8th, 2024